Large-scale copy number alterations are enriched for synthetic viability in BRCA1/BRCA2 tumors.

Genome Med · 2024 · PMC11351199 · PMID 39198848

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

As anticipated, bBRCA1/2 tumors displayed a higher proportion of their genome altered in ER+ BC, and TNBC than control tumors, and showed a trend towards a higher fraction of genome altered in OV tumors (Additional file 1: Fig.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.